Close
Achema middle east
swop processing & packaging

Orion Pharma Animal Health and Vetoquinol Enter Distribution Collaboration from 1 January 2015

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Recipharm supports landmark trial of next generation pneumococcal vaccine developed by ImmBio and iiCON

Recipharm delivers cGMP manufacture of PnuBioVax® enabling progression...

Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI

WALTHAM, Mass. (October 16, 2025) – Thermo Fisher Scientific Inc....

ACHEMA 2027: Global Forum for Pharma and Life Sciences

ACHEMA 2027 sets an even stronger focus on innovations...

Orion Pharma Animal Health and Vetoquinol have announced their collaboration regarding the distribution of Orion’s sedatives product family alpha-2 agonists and antagonist Dexdomitor, Domitor and Domosedan and Antisedan.

Vétoquinol will be the distributor in selected European countries for Orion sedative products. The collaboration is effective from 1 January 2015.

Vetoquinol is responsible for marketing the sedatives to customers in the UK, Germany, France, Ireland, the Netherlands, Belgium, Luxembourg and Italy.

Orion Pharma Animal Health vice-president Niclas Lindstedt said: “Orion Pharma Animal Health foresees that this new alliance with a dedicated and recognised partner will further strengthen the position with customers of the well-accepted Orion sedatives range.”

Vetoquinol CEO Matthieu Frechin said: “The inclusion of the sedative products from Orion Pharma Animal Health in our pain and surgery product range will further reinforce our offer to our customers; it is a an additional proof of our willingness to be a partner of choice for all vet surgeons in the field of pain and anaesthesia.”

Latest stories

Related stories

Recipharm supports landmark trial of next generation pneumococcal vaccine developed by ImmBio and iiCON

Recipharm delivers cGMP manufacture of PnuBioVax® enabling progression...

Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI

WALTHAM, Mass. (October 16, 2025) – Thermo Fisher Scientific Inc....

ACHEMA 2027: Global Forum for Pharma and Life Sciences

ACHEMA 2027 sets an even stronger focus on innovations...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »